The CaMKII Inhibitor, CK59, also referenced under CAS 140651-18-9, controls the biological activity of CaMKII. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.
A cell-permeable Olomoucine (Cat. Nos. 495620 & 495624) analog that acts as a CaMKII inhibitor (IC50<10 µM) and inhibits insulin-stimulated glucose uptake (IC50 ≤5 µM) and GLUT4 membrane translocation (IC50 = 100 µM) in 3T3-L1 adipocytes.
A cell-permeable Olomoucine analog that acts as a CaMKII inhibitor (IC50<10 M) and inhibits insulin-stimulated glucose uptake (IC50 ≤5 M) and GLUT4 membrane translocation (IC50 = 100 M) in 3T3-L1 adipocytes.
警告
Toxicity: Standard Handling (A)
再構成
Following reconstitution aliquot, and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
その他情報
Konstantopoulos, N., et al. 2007. Endocrinology, 148, 374.
法的情報
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany